Figure 7.

Analysis of MGFA scores showed a significant clinical improvement in the first 4 years of disease, but no further improvement afterwards (A), Kruskal–Wallis test (adjusted p-values: 0 vs. 1–4: p = 0.005 (**); 0 vs. 5–10: p = 0.0094(**); 0 vs. 11–20: p = 0.013 (*); 0 vs. 21–30: p = 0.01 (*). Clinical remission was indicated by an MGFA score of “0” to allow inclusion in the dataset. Simple linear regression with Spearman correlation. No significant reduction of MuSK IgG4 and IgG4 levels over time (B, C).